0001562180-20-005206.txt : 20200722
0001562180-20-005206.hdr.sgml : 20200722
20200722215801
ACCESSION NUMBER: 0001562180-20-005206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200720
FILED AS OF DATE: 20200722
DATE AS OF CHANGE: 20200722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sama Rinda
CENTRAL INDEX KEY: 0001756399
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 201042610
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics Modulation Technologies, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-07-20
false
0001603756
Axonics Modulation Technologies, Inc.
AXNX
0001756399
Sama Rinda
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
Chief Operating Officer
Common Stock
2020-07-20
4
M
false
13657.00
1.63
A
199931.00
D
Common Stock
2020-07-20
4
M
false
6943.00
14.19
A
206874.00
D
Common Stock
2020-07-20
4
S
false
19700.00
39.3326
D
187174.00
D
Common Stock
2020-07-20
4
S
false
900.00
40.1894
D
186274.00
D
Common Stock
2020-07-21
4
M
false
13127.00
14.19
A
199401.00
D
Common Stock
2020-07-21
4
S
false
10400.00
40.6934
D
189001.00
D
Common Stock
2020-07-21
4
S
false
4000.00
41.0999
D
185001.00
D
Common Stock
4000.00
I
By Spouse
Stock Option (Right to Buy)
14.19
2020-07-20
4
M
false
6943.00
0.00
D
2029-01-30
Common Stock
6943.00
68612.00
D
Stock Option (Right to Buy)
1.63
2020-07-20
4
M
false
13657.00
0.00
D
2028-03-30
Common Stock
13657.00
11543.00
D
Stock Option (Right to Buy)
14.19
2020-07-21
4
M
false
13127.00
0.00
D
2029-01-30
Common Stock
13127.00
55485.00
D
This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 18, 2020.
This transaction was executed in multiple trades at prices ranging from $39.14 to $40.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $40.16 to $40.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $40.00 to $40.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $41.00 to $41.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
/s/ Dan Dearen, as Attorney-in-Fact for Rinda Sama
2020-07-22